Colorectal Carcinoma
|
0.400 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Oculomotor apraxia
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Deglutition Disorders
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Dysarthria
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Nystagmus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Gait, Unsteady
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Absent reflex
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebellar Dysmetria
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dysdiadochokinesis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Romberg's sign positive
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Oculovestibuloauditory syndrome
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hypermetric saccades
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Distal muscle weakness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebellar atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Ataxia, Appendicular
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Sensorimotor neuropathy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Distal sensory impairment
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Nystagmus, CTCAE 3.0
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Nystagmus, CTCAE 5.0
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Squamous cell carcinoma of the head and neck
|
0.100 |
Biomarker
|
disease |
BEFREE |
The human X-ray repair cross-complementing gene 1 (XRCC1) is highly polymorphic in the cells of human head and neck squamous cell carcinoma lines and in a variety of other human cell lines.
|
1574572 |
1992 |
Head and Neck Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
Expression of the polymorphic human DNA repair gene XRCC1 does not correlate with radiosensitivity in the cells of human head and neck tumor cell lines.
|
1574572 |
1992 |
Xeroderma Pigmentosum
|
0.080 |
Biomarker
|
disease |
BEFREE |
The relative mRNA level of c-myc and XRCC1 genes was significantly increased 15 min after X-irradiation with doses of 2-8 Gy in ataxia telangiectasia (AT) cells (AT5BIVA and TAT2SF), in contrast to little change in xeroderma pigmentosum (XP2OS(SV) and XP2YO(SV)) and normal cells (WI38VA13 and GM0637).
|
7513822 |
1994 |
Ataxia Telangiectasia
|
0.010 |
Biomarker
|
disease |
BEFREE |
The relative mRNA level of c-myc and XRCC1 genes was significantly increased 15 min after X-irradiation with doses of 2-8 Gy in ataxia telangiectasia (AT) cells (AT5BIVA and TAT2SF), in contrast to little change in xeroderma pigmentosum (XP2OS(SV) and XP2YO(SV)) and normal cells (WI38VA13 and GM0637).
|
7513822 |
1994 |
Asphyxia Neonatorum
|
0.200 |
Biomarker
|
disease |
RGD |
mRNA levels of the hypoxia inducible factor (HIF-1) and DNA repair genes in perinatal asphyxia of the rat.
|
9763211 |
1998 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
We performed T cell cloning experiments with a tumor-infiltrating lymphocyte subpopulation derived from a renal cell carcinoma tumor site (RCC-7) in which the TCR clonotypic repertoire had been analyzed in terms of TCRBV complementarity-determining region 3 size distribution.
|
9973436 |
1999 |